Mediseek
en_ENfr_FR

Browse by alphabet

0 1 2 3 4 5 6 7 8 9
A B C D E F G H I
J K L M N O P Q R
S T U V W X Y Z

Common search terms

- mammary neuralgia
- dentinox infant colic drops
- nisoldipine
- lichen ruber planus
- oesophageal dysrhythmia
- saltpetre
- hyperpigmentation
- anaesthesia, inhalation
- myopia
- dextromethorphan
- granular leukocyte
- isthmus aortae
- fascia lata
- finger injuries
- salbutamol, ipratropium
- symptomatic
- splenic vein
- crab lice
- tacaribe virus
- haak
 
Pages for tromethamine
1
 

Acular TREATMENT

DMCA Copyright Information ... Acular (ketorolac tromethamine ophthalmic solution) 0.5% - Drug ... ... .. Acular (ketorolac tromethamine 0.5%) is the only NSAID approved for the ... ACULAR (ketorolac...
http://health.cd-writer.com/c1/p880/treatment_for/acular.html
2
 

Acular - Drug information from Medic8.com

Medic8® Drug Information ... Acular is the popular brand name of ketorolac tromethamine ophthalmic solution. ... Apotex Products Group, a Canadian manufacturer, offers generic Ketorolac tromethamine...
http://www.medic8.com/medicines/Acular.html
3
 

Ocular Surface Staining Appears More Often With Bromfenac: Presented at ARVOOcular Surface Staining Appears More Often With Bromfenac: Presented at ARVO

Unregistered User / If this is not your name, click here. ... Each of the 10 left eyes received ketorolac tromethamine 0.4% for 3 weeks. ... [Presentation title: Clinical Evaluation of Ocular Surface Toxicity of Ketorolac...
http://www.pslgroup.com/dg/25a572.htm
4
 

New and Generic Drug Approvals Drug Approvals - A

CDER New and Generic Drug Approvals: 1998-2004 / A - B - C - D - E - F - G - H - I/J - K - L - M - N - O - P - Q - R - S - T - U - V - W - X - Y - Z / Product Name Company Application # Approval / Date ... ACULAR (ketorolac...
http://www.fda.gov/cder/approval/index.htm
5
 

Research - School of Dental Sciences - Newcastle University

... The effects of topical ketorolac tromethamine mouthrinse (0.1%) on gingival crevicular fluid (GCF) prostaglandin E2 (PGE2) concentrations were investigated in a 6-week, randomized, double-blind, placebo-controlled,...
http://www.ncl.ac.uk/dental/research/publication/26857
6
 

FDA’s First New Drug Application Approval Based on PDA Patient Diary

FDA’s First New Drug Application Approval Based on PDA Patient Diary ... Allergan Inc. received the approval for its pharmaceutical ACULAR LS (ketorolac tromethamine ophthalmic solution) 0.4%, an ophthalmic non-steroidal...
http://www.pdacortex.com/FDA_PDA_Patient_Diary.htm
7
 

Ketorolac - Wikipedia

Ketorolac / From Wikipedia / Jump to: navigation, search ... Ketorolac or ketorolac tromethamine (marketed as Toradol® - generics have been approved) is a non-steroidal anti-inflammatory drug (NSAID) in the family of...
http://en.wikipedia.org/wiki/Ketorolac
8
 

Memis D, et al.Indomethacin-Induced Pancreatitis: A Case Report.JOP.J Pancreas (Online) 2005; 6(4):344-347. [Abstract]

CASE REPORT / JOP. J Pancreas (Online) 2005; 6(4):344-347. Indomethacin-Induced Pancreatitis: A Case Report / Dilek Memis, Esin Akalin, Tuba Yücel ... Famularo G, Bizzarri C, Nicotra GC. Acute pancreatitis caused by ketorolac...
http://www.joplink.net/prev/200507/05_c.html
9
 

eMedicine - Oliguria : Article by Prasad DevarajaneMedicine - Oliguria : Article by

Home / Specialties / Reference Centers ... Patients who cannot tolerate a large sodium load (eg, those with congestive heart failure) may be treated in an ICU setting with intravenous tromethamine (THAM), with provision of...
http://www.emedicine.com/ped/topic1637.htm
10
 

RBx 7,796: A novel inhibitor of 5-lipoxygenase. [Inflamm Res. 2006] - PubMed Result

NCBI / PubMed A service of the U.S. National Library of Medicine and the National Institutes of Health / My NCBI / [Sign In] [Register] / All Databases / PubMed / Nucleotide / Protein ... WY-50,295 tromethamine, a novel,...
http://www.ncbi.nlm.nih.gov/pubmed/17039282/
 
 
 
1 | 2 | 3 | 4 | 5 | 6 | 7 | >
 
 
Helpful links | About Mediseek | Company | Privacy policy | Contact
Vertical portal made by
www.seekport.biz

© 2007, Seekport Internet Technologies UK Ltd
Seekport Internet Technologies GmbH